Celltrion licenses Kaigene anti-APRIL antibody in autoimmune deal up to $580.5M
Celltrion expands beyond biosimilars with Kaigene’s KG013, a preclinical anti-APRIL antibody for IgA nephropathy and other autoimmune diseases.
This section contains the website’s posts.